Arrowhead Lead Scientific Advisor, Dr. Mauro Ferrari and Calando Pharmaceuticals’ siRNA Drug Delivery Platform …

Arrowhead Lead Scientific Advisor, Dr. Mauro Ferrari and Calando Pharmaceuticals’ siRNA Drug Delivery Platform …
Arrowhead Research Corporation (NASDAQ:ARWR) today announced that two articles of interest to Arrowhead stockholders appeared in the Houston Chronicle this week. An article published on May 24, entitled “Minute invaders that aid the body”, reports on the revolutionary potential of gene silencing and the pioneering role of the siRNA delivery system developed by Arrowhead majority-owned subsidiary …

Read more on SYS-CON Media

NANOFUSION! A Vitamin That Is Radically Different

A Vitamin That Is Radically Different.  NANOFUSION!

What makes Max N-Fuze any better than the thousands of other multi-vitamin supplements on the shelves today?

This is a great question!  N-Fuze is radically different than any other supplement in several ways:

N-Fuse One-of-a Kind Nanofusion technology has the best Absorption and Bioavailability on the market. N-Fuze is Purposeful with Targeted Nano-Nutrients for Optimal Cell Health. N-Fuze is Proven to be Safe and Effective. Best Absorption and Availability of Nutrients to our Cells.

 Looking back at point one, Consumption Does Not Equal Absorption.  Or, said another way, taking a vitamin does not insure that it will be absorbed but might just pass through and out during the elimination process.

Most supplements are a crap shoot. We do not know how much gets absorbed or even if it ever makes its way into the cells where it is most needed.

Max N-Fuze delivers targeted nutrients to cells for specific purposes through the bloodstream in less than 60 minutes rather than the usual 18-48 hours that it may take other supplements. This is done through a unique patent-pending Nanofusion delivery system. The introduction of Max N-Fuze is the first of its kind.

Some point out that Nano-technology has been around for a while. Most products claiming Nano-technology do not have the design of N-Fuze. Nano-sized particles can unfold and “re-aggregate” or “re-agglomerate” and actually become either bigger or even different than what they were intended and may not even fit the cell receptors.

I don’t mean to sound like a Dr. here but the term “Nano” has become a marketing flashpoint and some products that advertise “Nano” are using it without meeting the stringent requirements… much like using the term “natural’ or “organic” in marketing without real certification or under relaxed or no oversight. Or like “sugarless” really means the use of Aspertame.

N-Fuze is both radically different and arguably the best! N-Fuse nutrient particles are housed at 65 nanometers within water clusters so they are guaranteed to transport as designed… through the mouth tissues to the bloodstream and on into the cells as intended. The remainder is transported through the rest of the digestive tissues in the same manner. (The criterion for calling something “Nano” is that it must have a dimension of 100nm or less.)

ONLY THE MAX CELLULAR TRANSPORT SYSTEM process can create a stable water cluster capable of passing through the bloodstream directly into tissues at the cellular level.

Drug Delivery Markets: Implantable / Injectable And Needle-Free Delivery Systems

With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.

Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:

Needle-free drug delivery

Other Injectable/Implantable

Kalorama’s unique analysis offers segmentation of this market for:

Drug Delivery Technology Revenues

Pharmaceuticals Sold via Delivery Technology

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these separate markets)

The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:

Detailed Profiles of Key Companies in Implantable/Injectable Delivery

Brief Round-Up of Smaller Players

Current Market Size and Forecasts to 2013

Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other Trends and Developments

Revenue Forecasts

New Products in Development

Kalorama’s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Companies Profiled in the report include:

Alkermes, Inc.

ALZA Corp.

Antares Pharma, Inc.

Bioject Medical Technologies, Inc.

CyDex, Inc.

MGI Pharma, Inc

Nektar Therapeutics

Pacira Pharmaceuticals, Inc.

pSivida

SurModics, Inc

Zogenix Corporation

AP Pharma

Baxter BioPharma Solutions

QLT USA, Inc

Ypsomed Holding AG

Kalorama has also published Drug Delivery Markets: Oral Delivery, which details markets for oral technology enhancements which have increased drug product sales and extended patent life.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1655/Drug-Delivery-Markets-Implantable-Injectable-and-Needle-Free-Delivery-Systems.html

Contact Us:

Visionshopsters
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Nanopatch: The Future of Vaccinations

Nanopatch: The Future of Vaccinations
Scientists at the Australian Institute for Bioengineering and Nanotechnology have just unveiled a new technology that could change the world and save millions (billions?) of lives. The Nanopatch is an alternative vaccine delivery system that induces the s…

Read more on I4U